Impetiginous Cutaneous Leishmaniasis after COVID-19 Infection in a Patient with Poor Cardiac Profile: A Case Report and Literature Review

Cutaneous leishmaniasis incidence has been rising in the past couple of decades. Standard therapy often includes antileishmanial drugs; however, due to their low safety and toxicity threshold, alternative treatments are being investigated. The association between COVID-19 and cutaneous leishmaniasis...

Descripción completa

Detalles Bibliográficos
Autores principales: Alotaibi, Hend, Aldossari, Abdulelah, Alnasser, Sultan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10536164/
https://www.ncbi.nlm.nih.gov/pubmed/37755904
http://dx.doi.org/10.3390/tropicalmed8090443

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10536164/
https://www.ncbi.nlm.nih.gov/pubmed/37755904
http://dx.doi.org/10.3390/tropicalmed8090443

Ejemplares similares